97%
of participants agreed the tablet was easier to administer.
When the truth is simply too hard to swallow.
A smaller formulation for delivering difficult truths through an alternative route selected after several uncomfortable meetings with Regulatory Affairs.

We listened
Some patients reported that Acceptitol™ tablets required extensive chewing, prolonged emotional preparation, and occasionally a second calendar reminder before administration could be completed.
Acceptitol™ PR (Posterior Release™) bypasses the swallowing process entirely, delivering difficult truths through an alternative route chosen after several uncomfortable meetings with Regulatory Affairs.
Indication
For adults who cannot comfortably swallow life-changing realizations, inconvenient facts, or the original Acceptitol™ tablet.
Benefits
Clinical results
In a randomized internal study with participation requirements that are now being reviewed by People Operations.
97%
of participants agreed the tablet was easier to administer.
84%
immediately regretted participating.
100%
requested that future surveys be conducted online.
Most common side effects
If symptoms of accountability persist for more than four hours, congratulations. The product is functioning as intended.
Important safety information
Do not use Acceptitol™ PR if you are allergic to Acceptitol™, pharmaceutical innovation, difficult conversations, or consequences.
Do not crush, split, microwave, grill, or attempt to administer two doses simultaneously simply because “it’ll save time.”
Patients should not operate heavy machinery until they have fully processed the truth.
Customer testimonial
“I told my doctor I couldn’t swallow the original. He said there were alternatives. I should have asked more questions.”
Because some truths
were never meant to go down the traditional way.
Posterior Release™
Delivering uncomfortable realities through innovative pharmaceutical engineering and increasingly questionable product management.